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Abstract
Purpose Personalised information and support can be provided to cancer survivors using a structured approach. Needs assess-
ment tools such as the Holistic Needs Assessment (HNA) in the UK and the Comprehensive Problem and Symptom Screening
(COMPASS) questionnaire in Canada are recommended for use in practice; however, they are not widely embedded into
practice. The study aimed to determine the extent to which nurses working in cancer care in the UK and Manitoba value NA
and identify any barriers and facilitators they experience.
Method Oncology nurses involved in the care of cancer patients in the UK (n = 110) andManitoba (n = 221) were emailed a link
to an online survey by lead cancer nurses in the participating institutions. A snowball technique was used to increase participation
across the UK resulting in 306 oncology nurses completing the survey in the UK and 116 in Canada.
Results Participants expressed concerns that these assessments were becoming bureaucratic “tick-box exercises” which did not
meet patients’ needs. Barriers to completion were time, staff shortages, lack of confidence, privacy, and resources. Facilitators
were privacy for confidential discussions, training, confidence in knowledge and skills, and referral to resources.
Conclusion Many busy oncology nurses completed this survey demonstrating the importance they attach to HNAs and
COMPASS. The challenges faced with implementing these assessments into everyday practice require training, time, support
services, and an appropriate environment. It is vital that the HNA and COMPASS are conducted at optimum times for patients to
fully utilise time and resources.
Keywords Cancer . Cancer survivorship . Recovery package . Holistic needs assessment . COMPASS
Background
The United Kingdom (UK) and Canada have similar public
healthcare systems which are struggling to manage the needs of
increasing numbers of patients diagnosed and treated for cancer
[1, 2]. In 2010, a report published by the National Cancer
Survivorship Initiative (NCSI) in the UK stated that people who
have been diagnosed and treated for cancer face many long-term
difficulties and need support and information to livewell with and
beyond the cancer diagnosis [3]. The NCSI advocated that sup-
portive care for cancer survivors should be given equal
importance to acute care, with a prominent focus on self-
management [3]. The Cancer Strategy for England Report
(2015), in line with the NCSI report, suggests that patients should
be supported to manage their cancer effectively as a chronic con-
dition [1, 4, 5]. In Canada, emotional distress has been branded as
the “6th vital sign”, granting it prominence in oncology alongside
the traditional five vital signs, and requiring cancer programs to
implement appropriate distress screening protocols [6].
To ensure cancer survivors’ optimum health and wellbeing, a
structured approach to assessing people’s physical, practical,
emotional, spiritual, and social needs has been recommended in
the UK and Canada. In the UK, the Holistic Needs Assessment
(HNA) is a pivotal component in the development of a Recovery
Package for peoplewith cancer. TheRecovery Package, which is
a national initiative in the UK, is intended to not only improve
communication about care needs between secondary and prima-
ry care but aims to provide people with the information and
support they need to enable them to return to work, self-manage,
and live their lives well [4, 7], [http://www.ncsi.org.uk/what-we-
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are-doing/the-recovery-package/]. Elements of the Recovery
Package are as follows: Holistic Needs Assessment, Treatment
Summary, Cancer Care Review, and Health and Wellbeing
Clinics. Key time points suggested for conducting the HNA are
at diagnosis, after completion of treatment, at discharge from
routine follow-up, at episodes of disease recurrence, and at
transition from active to palliative care [http://www.ncsi.org.uk/
what-we-are-doing/the-recovery-package/]. In Canada, a
guideline developed by the Canadian Partnership against
Cancer and the Canadian Association of Psychosocial
Oncology recommends that all cancer patients be routinely
screened for distress, contributing problems and associated
concerns [8]. Similar to the UK, this screening should take
place at the initial visit, at appropriate intervals, and whenever
clinically indicated, using brief, validated tools. In Manitoba, a
Canadian province, distress screening is expected to be
performed at every patient visit using the Comprehensive
Problem and Symptom Screening (COMPASS) questionnaire.
This is comprised of modified versions of the Edmonton
Symptom Assessment Scale [9] and the Canadian Problem
Checklist [6] which asks patients to indicate items that were a
source of worry or concern during the previous week from seven
domains (Physical, Practical, Emotional, Spiritual, Informational,
Social/Family, and Dignity) [10]. In Manitoba, clerical staff en-
sure that patients complete the COMPASS, while nurses are
responsible for using the COMPASS scores to respond accord-
ing to the national guideline [8].
In theUK, there is an expectation that clinical nurse specialists
(CNSs) working in cancer care will perform the HNA, as their
role is to coordinate care, provide technical and psychosocial
information, and emotional support [http://www.ncsi.org.uk/
what-we-are-doing/the-recovery-package/] [11]. The
information collated in the HNA should, in conjunction with a
risk stratification strategy, inform the patients individual care
pathway and ensure information and support is provided that is
tailored to patients’ individual needs [12]. However, it is
acknowledged that completion of the HNA is not widely
embedded into practice [13, 14]. In Canada, there is no
designated oncology professional for distress screening efforts,
but usually clerical or nursing staff ask the patients to complete
the screening questionnaires. In Manitoba, oncology nurses are
responsible for using the COMPASS scores to open up a
conversation with the patient and respond to distress according
to national guidelines [8]. The guidelines state that patients who
score high on distress should have a comprehensive assessment
of their distress to identify the sources and magnitude of distress,
and associated risk factors. Using a stepped-care approach, all
patients should be offered education and support, followed by a
tailored psychosocial intervention based on the intensity (mild,
moderate, severe) of their distress. The clinical success of initial
distress screening efforts is critically dependent on a subsequent,
more comprehensive assessment of the patient, based on the
patient’s COMPASS score.
A number of barriers have been identified that may prevent
CNSs from carrying out a HNA including CNS shortages, lack
of time, concern about causing distress to patients, lack of confi-
dence in ability to answer difficult questions, the organisational
culture being disease rather than patient focussed, and lack of
training and support [15, 16]. In Canada, the perceived value of
distress screening is mixed. One survey found that 38% of on-
cologists regard distress screening as impractical, and 43% of
nurses and radiographers report that distress screening is not
useful [17]. A second study found that once distress screening
efforts were underway, staff were enthusiastic about the process
and appreciated the associated training [18]. Others reported that
distress screening provides ameans of demonstrating quality care
to patients and coordinating care [19].
Assessment of patients’ individual needs should be at the
core of any self-management approach to care and it may be
that this information is being collected through other means
and not labelled or identified as a HNA or COMPASS evalu-
ation. Conversely, institutions may be implementing the
HNA/COMPASS successfully but not formally reporting on
their progress; this remains unexplored. In the UK, patient
access to CNSs varies geographically and by tumour site,
which is problematic if a HNA is a pivotal aspect of planning
a care pathway [13]. Tailored care pathways were being de-
veloped and implemented, but not always based on a Needs
Assessment (NA). CNSs also felt that it was challenging to
undertake risk stratification without a completed NA,
compounding efforts to provide patients with tailored self-
management care pathways.
The aim of this study was to determine the extent to which
nurses working in cancer care in the UK and Manitoba value
NA and identify any barriers and facilitators they experience.
Study objectives
To identify:
1. What constitutes a NA at different localities, including the
assessment time points
2. Whether oncology nurses perceive the assessment as ben-
eficial for patients and a key component of care planning
3. What barriers/facilitators inhibit/assist oncology nurses in
carrying out the assessment
4. Recommendations for incorporating the NA into routine,
clinical practice
Methods
A questionnaire was developed for completion online using
SurveyMonkey to establish whether nurses working in cancer
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care use a NA, when they use it, and the perceived barriers and
facilitators to using it. Informal discussions with oncology
nurses in the UK and Manitoba identified similar concerns
about the patient needs assessments including the timing, fre-
quency, and value of the assessment.
Items for inclusion in the survey were derived from the
literature and informal discussions with nurses working in
oncology, lead cancer nurses and patient groups in the UK
and Manitoba which have similar practices and models of
care. Although reliability and validity were not formally test-
ed, questions were refined and tested by lead cancer nurses
until they were satisfied that wording and questions were clear
and in the right format. Small changes were made to each
question, and some were altered to reflect differences in rec-
ommended practice in the UK and Manitoba. The question-
naire was then completed by two oncology nurses who were
not going to participate in the online survey.
The final version included 24 questions, 19 closed with an
“other” option if the closed responses did not represent their
practice, and 5 open-ended. Respondents were asked if pa-
tients had a NA, the timepoints in the care pathway at which
it was completed, how long it took to complete, and how the
information collected was used. Other questions asked about
training, barriers, and facilitators to conducting a NA includ-
ing ticking concerns from the list in the COMPASS/HNA
document that they found difficult to discuss with patients.
Lastly, they were asked to indicate the type of hospital or
community practice they worked in, which cancer group they
worked with and the country they worked in.
Sample and recruitment
Lead cancer nurses in the Lancashire and South Cumbria re-
gions (LSC) in the UK and Manitoba were asked to forward
an email with a link to the online survey to a convenience
sample of all oncology nurses who had responsibility for com-
pleting a NA.
In addition, a snowball sampling technique was used to
recruit CNSs working in cancer care across the UK through
their national societies. The survey link was advertised
through the UK Oncology Nursing Society, British
Psychosocial Oncology society, and Macmillan Cancer
Support newsletters/websites. In Manitoba, the link to the sur-
vey was distributed to the managers of oncology nursing of
several regional health authorities who sent the survey link to
CancerCare Manitoba nursing staff. The inclusion criteria
were all nurses working in cancer care who would have re-
sponsibility for completing a Needs Assessment for patients,
regardless of duration of work experience. Oncology nurses
who did not have responsibility for completing a needs assess-
ment were excluded. When potential participants opened the
link to the survey, they were presented with information about
the study. After reading the information, they could then
choose whether or not to continue to the survey. This infor-
mation page also provided contact details for the research
team, assurances that participation was voluntary, and that
responses would only be seen by the research team at the
university. Consent was provided through anonymous partic-
ipation. Data were collected between May 2017 and
November 2017. Ethical approval was gained from the
University of Central Lancashire in England, the Health
Research Ethics Board at the University of Manitoba, and
the Regional Health Authority Research Ethics Committees
in Manitoba: Winnipeg, Southern Health, Interlake/Eastern,
and Northern Health.
Analysis
The quantitative data from closed responses were exported
from Microsoft Excel into SPSS for Windows (version 22)
and analysed using descriptive statistics to establish frequen-
cies. Responses from the UK were cross tabulated with re-
sponses from Canada. For brevity, the number (n) and per-
centage of participants who gave specific answers are report-
ed. The qualitative data from the responses to open-ended
questions were uploaded into NVivo and analysed using con-
tent analysis [20].
Results
Initially, 110 CNSs were invited to participate across LSC and
80 (73%) responded. A snowball technique was used for fur-
ther recruitment, and 306 responses were received
representing England, Scotland, Wales, and Northern
Ireland. In Manitoba, 221 oncology nurses were invited to
participate and 116 (52.5%) responded. Not all questions were
answered by all, and totals represent the number of valid re-
sponses to questions. Many respondents used the “other” sec-
tion of closed responses to explain or add to their forced
choice. Representative quotations from these responses are
provided throughout the results section.
Sample characteristics
In the UK, most respondents worked in secondary care
(90%, n = 187) with the remaining 10% (n = 28) working
in primary care or in integrated posts. In Manitoba, all
respondents worked in either secondary or quaternary care
(100%), n = 116. All respondents worked across a broad
range of cancer specialities so we can be confident that
practice and issues described were not limited to one
speciality.
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Completing and utilising the HNA/COMPASS
Respondents reported that the majority of cancer patients had
received a NA in the UK (96% n = 260), and in Manitoba
(91%, n = 130). There were differences with the way the NA
was completed; mainly face to face with patients in the UK
(86%, n = 204) and self-completed by patients in Manitoba on
arrival at the oncology clinic for discussion during their appoint-
ment (97%, n = 110). Slightly more than half of UK respondents
(52%, n = 119, N = 227) completed the NA with patients at or
near point of diagnosis, and only 9% (n = 20) completed the NA
at every appointment (Fig. 1a). This contrasts with the much
higher percentage of Manitoba respondents who discussed a
NA at every appointment (66%, n = 71, N = 108) (Fig. 1b). In
the UK, the rate of completion of the NA during follow-up
decreased over time: 32% of respondents completed the NA at
about 6–8 weeks following completion of treatment (n = 72),
while only 8% of respondents completed the NA at about 12–
18 weeks following completion of treatment (n = 19). During
follow-up, the percentage of Manitoba respondents who com-
pleted COMPASS (20%, n = 22) did not differ greatly from
the percentage of respondents who completed the HNA during
treatment (23%, n = 25). In the palliative care stage, 18% of UK
respondents completed a NA (n = 41), compared with just 10%
of Canadian respondents (n = 11). The majority of respondents
indicated that the NA was used to develop individualised care
plans in the UK (89%, n = 213), while in Manitoba, it was used
to inform psychosocial and family support service needs (77%,
n= 86). The time points at which theHNA andCOMPASSwere
completed is shown in Fig. 1a and b.
Information relating to the NA was collected through a
combination of means, primarily through both electronic and
paper records in the UK (39%, n = 91), and electronic records
in Manitoba (75%, n = 85). Across the UK, 10% (n = 22) of
respondents said it took them less than 10 min to go through
the HNA checklist with 77% (n = 176) saying it took them
more than 10 min. In Manitoba, 81% (n = 91) said the
COMPASS took less than 10 min with 8% (n = 9) saying it
took them more than 10 min.
Training
Most respondents in the UK (145/244, 59%) and Manitoba
(90/113, 80%) had received training on how to deliver the
NA. The majority had found the training adequate (UK
89%, Manitoba 84%).
An open-ended question asked respondents to comment on
what training would be useful. A total of 132 responses were
received (n = 70 for the UK, n = 62 for Manitoba). The re-
sponses were collapsed into the following categories:
a
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& General training on NA—such as observing someone ex-
perienced in NA, and training to develop care plans.
& Communication training—how to broach sensitive issues,
and training to improve confidence in dealing with sensi-
tive issues.
& How to implement the NA into practice, rather than a
bureaucratic tick box exercise
& Following up on NA—Respondents were not sure what
they could do with the information received from patients,
or whom they could refer patients to if necessary.
All respondents were concerned that the NA would be-
come a bureaucratic exercise, not allowing time to go through
it with patients and provide the necessary support and infor-
mation that patients need. The expectation of nurses to act
upon the NAwas an area respondents felt needed clarification.
How to help patients once issues have been identified was a
key area for many.
Why dowewant to know andwhat are we offering to do
to address the concerns patients raise? At the moment it
seems like a tick box exercise, we ask people for infor-
mation we have no plan or means to do much with (UK
48).
List of resources for the patient if they have identified a
barrier to care or to their health (MB 102).
Barriers and facilitators to completing needs
assessments
Lack of time and staff shortages were the largest barriers to
completing the NA in both groups of respondents (Fig. 2). In
particular, the percentages of those who identified these
problems as barriers were higher for theManitoba respondents
than for the UK respondents.
An open-ended question asking what additional
COMPASS/HNA training respondents would find useful
was answered by 72 (24%) respondents in the UK and 38
(23%) in Manitoba. Responses were collapsed into 4 main
categories:
1. Lack of resources; including being unable to refer patients
to appropriate support.
2. Timing of NA being inappropriate; respondents were not
comfortable discussing some issues with patients at the
time points suggested for completion of the NA.
3. Unsuitable environment; lack of privacy in clinics and
wards and patients being unwilling to discuss sensitive
issues in front of accompanying relatives were perceived
as a barrier to personal conversations.
4. No process to map trends.
I feel it is inefficient not being able to trend previous
results to see if the level of pain/nausea etc. has been
changing to help guide assessment and management
(MB 64).
I think information re: an overview of where to signpost
patients to. Services change and although you identify a
problem, I don’t always know where to go to with it
(UK 300).
Respondents were asked to indicate on a checklist any is-
sues from the COMPASS or HNA tool that they found diffi-
cult to discuss with patients. The majority found Sexuality,
Financial issues, Emotional concerns, and Spirituality difficult
to discuss with patients. Even though this question did not ask
specifically about barriers, many respondents added that they
found certain issues difficult to discuss because they did not
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know where to refer the patients if necessary. Only 5 respon-
dents did not find any topics difficult to discuss with patients.
Facilitators to completing the HNA/COMPASS included
suitable physical environments for private discussions (for
matters of a sensitive nature) together with adequate training
to enhance the knowledge of HNA/COMPASS and its imple-
mentation, and the availability of resources to refer patients for
additional support.
Directory of services etc. that you can signpost pts to as
appropriate when problems identified. Referral path-
ways to services (UK 143).
Discussion
This study aimed to assess the extent to which oncology
nurses perform a comprehensive, patient needs assessment
of patient symptoms, problems, and needs, and identify
barriers and facilitators to implementation of these assess-
ments. We provide evidence that in the UK, the CNSs do
complete the HNA but this is primarily carried out prior to
and immediately after treatment, but not for all patients.
Whereas in Manitoba, the COMPASS is completed by
patients at every appointment but not always discussed
with them by oncology nurses. In the UK, although other
clinicians may conduct a HNA, CNSs are the clinicians
who are recognised in policy documents in the UK as
playing a key role in the provision of information and
support to patients (http://www.ncsi.org.uk/what-we-are-
doing/the-recovery-package/; http://www.macmillan.org.
uk /Documents /AboutUs/Research / Impac tBr ie fs -
ClinicalNurseSpecialists2014.pdf) [4, 11, 12]. It was clear
that respondents in this study felt they had increasing and
competing demands on their time. The Independent
Cancer Taskforce reports that not only are numbers of
CNSs insufficient in many cancer specialities but their
time is frequently used inefficiently [4]. The respondents
in this study cited lack of time to complete the HNA, and
this may be why so many indicated that they did not
routinely assess patients’ holistic needs at 12–18 months
post treatment and prior to discharge. Indeed, this “lack of
time” barrier prompted CancerCare Manitoba to ask cler-
ical staff to ensure that patients complete the COMPASS
routinely upon every clinic visit. Utilising clerical staff in
this manner was intended to enable oncology nurses to
spend time with patients, exploring their COMPASS re-
sponses and having conversations about identified prob-
lems and concerns. However, oncology nurses in
Manitoba expressed equal concerns to their counterparts
in the UK, citing lack of time to adequately address
patient concerns and not knowing who to refer patients
to if required.
Although most patients cope reasonably well post-treat-
ment, a study of patients with head and neck cancer found
significant numbers had unmet needs up to 5 years after com-
pletion of treatment [21]. These unmet needs covered a broad
range of issues including tiredness and fatigue, worry and
depression, physical concerns related to treatment, and fear
of recurrence [21]. While some suggest that fear of recurrence
diminishes over time, most agree that emotional concerns,
worry, and depression continue for years post-treatment
[21–24]. Moreover, the Cancer Patient Experience Survey
reported that, while access to a CNS is the most important
factor contributing to a positive patient experience, significant
numbers do not receive the emotional support they need or the
opportunity to discuss fears and worries [12]. The respondents
in this study suggest that lack of clear referral pathways, lack
of time, lack of privacy, and lack of confidence are the reasons
patients have limited opportunities to discuss psychosocial
issues. In Canada, this reality spawned a national training
effort to instruct oncology nurses on how to respond therapeu-
tically to patient reports of distress (anxiety, depression, fa-
tigue, and pain). This comprehensive training program, in-
cluding didactic online courses and reflective practice, signif-
icantly raised the confidence levels of nurses [25].
Other studies also report that lack of confidence, feeling
over-burdened, and being ill prepared to deal with psychoso-
cial distress are concerns for those tasked with completing the
HNA [16, 24, 26, 27]. The respondents to this survey sug-
gested that lack of privacy was a barrier for patients, either
because relatives were present or because the clinic or ward
environment was not conducive to personal discussions.
Biddle et al. (2016) also suggested that some patients were
unwilling, or found it difficult, to discuss psychosocial issues
which will impact on the successful implementation of the
recovery package in the UK and compliance with national
guidelines in Canada, http://www.ncsi.org.uk/what-we-are-
doing/the-recovery-package/ [8, 26].
Implications for practice
Clinical staff need training, support, and clear referral path-
ways in order to feel confident in their ability to support pa-
tients who have psychosocial difficulties. The issue of
protected time and flexibility also needs to be addressed as,
while respondents in this study said that lack of time was a
barrier to completing the NA, and they also said that the
timing of the NA was not always appropriate for patients. In
addition, they reported that patients were not always prepared
to discuss psychosocial difficulties and attributed this to lack
of privacy. If lack of privacy is a barrier, it might be easier for
patients and staff to discuss sensitive issues on the telephone
as patients treated for breast, colorectal, and endometrial
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cancer found it easier to discuss sensitive issues over the
phone [28–30]. While the clinical practice environments in
the UK and Canada differ in their organizational structures
and service delivery approaches, these environments have
similar barriers with respect to availability of time and need
and desire for education and training. Efforts to comprehen-
sively assess cancer patients’ symptoms, problems, and needs
will fall short of national guidelines for clinical and psycho-
social care in the UK and Canada unless the institutions de-
livering care are restructured to involve all levels of adminis-
trative and clinical staff to adopt a truly patient-centred ap-
proach to care. An example of this type of larger scale effort
is taking place in Australia, where researchers are developing,
implementing, and evaluating a comprehensive program
called ADAPT for routine assessment and management of
cancer patient distress [31].
Limitations
Once further recruitment using snowballing in the UK accel-
erated, it was not possible to know howmany nurses had been
sent the link to the survey and how many had chosen not to
participate. Therefore, we do not know the true response rate
for the larger UK population. It is also possible that there was
selection bias in the sample, with those who chose to partici-
pate and complete the survey having strong opinions about the
HNA.
Conclusion
This study has identified a number of important barriers and
facilitators to completion of a NA. That so many busy nurses
working in oncology felt so strongly about the implementation
of a NA that they were prepared to complete this survey and
take the time to elaborate on forced choice responses demon-
strates the importance they attach to the topic. They did not
dispute the benefit of the NA to patients. However, the chal-
lenges they face with introducing the NA as part of everyday
practice require investment in training, time, support services,
and environment. With the financial pressures facing health
services in the UK and Canada, further research is needed to
ensure that the NA is conducted at optimum times for those
patients who need it to make the best use of patient and staff
time.
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